Octopus Biosafety SA (FR:MLOCT) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Octopus Biosafety SA has announced the resumption of its listing on Euronext Access Paris, effective December 16, 2024, following a commercial court’s decision to extend the observation period until May 2025. The company’s shares had been previously suspended due to a potential asset sale amid liquidation concerns.
For further insights into FR:MLOCT stock, check out TipRanks’ Stock Analysis page.